Blood cancers, High grade lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at the combination of rituximab with CODOX-M and IVAC chemotherapy, for diffuse large (DLBCL).
The trial was open for people to join between 2008 and 2013. The team published the results in 2020.
Recruitment start: 1 May 2008
Recruitment end: 2 April 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Andrew McMillan
Bloodwise
Experimental Cancer Medicine Centre (ECMC)
Haematology Trials Group
NIHR Clinical Research Network: Cancer
Last reviewed: 21 April 2024
CRUK internal database number: 736
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
